Article in Movement disorders clinical practice, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
9 authors.
Haotian ZouDepartment of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Yuanyuan GuoDepartment of Biostatistics and Bioinformatics, Duke University, Durham, North Carolina, USA.
Christopher G GoetzDepartment of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA.ORCID 0000-0003-1665-8205
Tiago A MestreOttawa Hospital Research Institute, University of Ottawa Brain and Mind Research Institute, Ottawa, Ontario, Canada.ORCID 0000-0002-6973-7479
Glenn T StebbinsDepartment of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA.
Falah Al-HajrafNuffield Department of Clinical Neurosciences, Division of Clinical Neurology, University of Oxford, Oxford, UK.
Michael LawtonDepartment of Population Health Sciences, University of Bristol, Bristol, UK.
Michele HuNuffield Department of Clinical Neurosciences, Division of Clinical Neurology, University of Oxford, Oxford, UK.ORCID 0000-0001-6382-5841
Sheng LuoDepartment of Biostatistics and Bioinformatics, Duke University, Durham, North Carolina, USA.ORCID 0000-0003-4214-5809
Funding
Resource Core 3 - Metabolomics CoreP30AG028716 · NIA · DUKE UNIVERSITY · PI CATHLEEN S COLON-EMERIC · 2006 to 2026
$24.6M
Research Education Component CoreP30AG072958 · NIA · DUKE UNIVERSITY · PI GWENN A GARDEN, Heather E. Whitson · 2021 to 2026
$24.1M
Integrative modeling and dynamic prediction of Alzheimer's diseaseR01AG064803 · NIA · DUKE UNIVERSITY · PI LUO, SHENG · 2020 to 2024
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Co-Existent Probable RBD and PD: Disease Progression, Medication Response, and Clinical Trial Implications. · full record | OpenQuestion